Who We Are

We want to provide opportunities to develop skills in the areas of #clinicaltranslation & commercialisation of #regenerativemedicine. We have an opportunity for a PhD Candidate / #PostDoc to attend #SummerByDesign w/ a travel award. Pls Share widely. ow.ly/h1Wh30nJutg pic.twitter.com/v95m4waz5s

7:00 am · February 18, 2019

CCRM_au

@CCRM_au

Announced this morning: @MTPConnect_AUS to administer the Biomedical Translation Bridge Program w/ @BioCurate, @UniQuestUQ & the Medical Device Partnering Program. The program will support the translation of Australian medical research through to proof of concept stage. twitter.com/MTPConnect_AUS…

10:50 pm · February 17, 2019

CCRM_au

@CCRM_au

The latest global industry briefing showed that 2018 was a year of significant growth in the #regenerativemedicine sector, with a rich & diverse pipeline producing positive data & attracting the attention of investors. ow.ly/TBSw30nHQmd #regenmed #stemcells @CCRM_ca pic.twitter.com/bALaEgeSQ4

7:30 pm · February 17, 2019

CCRM_au

@CCRM_au

Summary of key findings from @cynatastemcells CYP-001 preclinical model which examined the efficacy & action of CYP-001 in reference to acute graft versus host disease (#GvHD). #cynatatherapeutics #stemcells #regenmed #regenerativemedicine #organtransplant twitter.com/cynatastemcell…

11:33 pm · February 14, 2019

CCRM_au

@CCRM_au

Australian #RegenMed company @OrthocellLtd report high success rates w/ their #stemcell therapy Ortho-ATI® which is used in the treatment for chronic tendon injuries. Read the full story below on this great Australian success story. twitter.com/OrthocellLtd/s…

11:24 pm · February 14, 2019

CCRM_au

@CCRM_au

As #stemcell therapies move through #clinicaltrials & get closer to the clinic they are giving rise to new challenges around costs & likelihood of reimbursement, bringing to light growing concerns around reimbursement of cell therapies in Aus & globally. ow.ly/tWVs30nH0sf pic.twitter.com/Q60biRTqfm

7:45 am · February 14, 2019

CCRM_au

@CCRM_au

Our Industry Consortium members @cynatastemcells explains 'Graft-versus-host disease' (#GvHD) in this graphic and how they are working towards reducing the high mortality rates associated with #GvHD. #cynatatherapeutics #stemcells twitter.com/cynatastemcell…

10:23 pm · February 13, 2019

CCRM_au

@CCRM_au

Congrats $OCC twitter.com/orthocellltd/s…

5:25 am · February 11, 2019

CCRM_au

@CCRM_au

Today at CCRM Australia, we're celebrating the International Day of Women and Girls in Science! It's a pleasure to be part of building a better today and tomorrow for those in #regenmed. #WomeninSTEMM #WomeninSTEM #WomeninScience pic.twitter.com/N6nd4lYP02

3:10 am · February 11, 2019

CCRM_au

@CCRM_au

We're reflecting back on a great 2018 by remembering our CEO, @sivio12’s trip to #Israel for the #memorandum signing of Israel joining the CCRM network to advance #regenmed both globally and locally. Read more about the collaboration here: ow.ly/bGZp30nknei pic.twitter.com/dB2YukblGC

8:35 am · January 21, 2019

Who We Are

The CCRM Australia Council

The CCRM Australia Executive Team

The CCRM Australia Industry Interface

The Scientific Advisory Board